「will」の検索結果
23件：6～10件目を表示
-
er, no guidelines or evidence-based therapies have been established in the world for CRAO2) . Senju will work diligently to develop SJP-0008 as a new therapy for such a serious disease with the aim of...
https://www.senju.co.jp/system/files/content_news/2024-05/ENG_20240509.pdf -
hyperemia and is effective for Conjunctival hyperemia. The release date and product specifications will be announced at a later date. Overview of the Product Product name Mytear LUMIFY Category OTC d...
https://www.senju.co.jp/system/files/content_news/2024-08/ENG_20240903_0.pdf -
eatment of glaucoma and ocular hypertension. Pharmaceutical information activities for this product will be conducted jointly by Senju Pharmaceutical Co., Ltd. (manufacturer and distributor) and Otsuk...
https://www.senju.co.jp/system/files/content_news/2025-09/ENG_20250904.pdf -
er, no guidelines or evidence-based therapies have been established in the world for CRAO2) . Senju will work diligently to develop SJP-0008 as a new therapy for such a serious disease with the aim of...
https://www.senju.co.jp/system/files/content_news/2024-05/ENG_20240509_0.pdf -
Supplement business | Business Activities | About Senju | SENJU Pharmaceutical
he health of all people: the promotion of people’s health every day. In the Supplement business, we will provide wellness items that are considerate of people’s needs and free of pharmaceutical produc...
https://www.senju.co.jp/english/about/business/ec.html